We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS Recalls Coumadin for Possible Potency Issue
BMS Recalls Coumadin for Possible Potency Issue
June 6, 2011
Bristol-Myers Squibb (BMS) recently announced that it is recalling one lot of 1,000-count Crystalline 5mg tablets of its anticoagulant Coumadin (warfarin sodium), due to a possible potency issue discovered after a return.